These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11487198)

  • 1. Chronic delusional hallucinatory psychosis in early-onset Parkinson's disease: drug-induced complication or sign of an idiopathic psychiatric illness?
    Cannas A; Spissu A; Floris GL; Saddi MV; Cossu G; Melis M; Tacconi P; Milia A; Mascia MM; Giagheddu M
    Neurol Sci; 2001 Feb; 22(1):53-4. PubMed ID: 11487198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hallucinations and sleep disturbances in Parkinson's disease.
    Kulisevsky J; Roldan E
    Neurology; 2004 Oct; 63(8 Suppl 3):S28-30. PubMed ID: 15505140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early dopaminergic drug-induced hallucinations in parkinsonian patients.
    Goetz CG; Vogel C; Tanner CM; Stebbins GT
    Neurology; 1998 Sep; 51(3):811-4. PubMed ID: 9748031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.
    Fénelon G
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):18-25. PubMed ID: 18323763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When a Parkinson's disease patient starts to hallucinate.
    Poewe W
    Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delusional misidentification in association with parkinsonism.
    Roane DM; Rogers JD; Robinson JH; Feinberg TE
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):194-8. PubMed ID: 9608408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-induced hallucination and cerebral blood flow in Parkinson's disease.
    Okada K; Suyama N; Oguro H; Yamaguchi S; Kobayashi S
    J Neurol; 1999 May; 246(5):365-8. PubMed ID: 10399867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic nucleus stimulation for Parkinson disease with severe medication-induced hallucinations or delusions.
    Umemura A; Oka Y; Okita K; Matsukawa N; Yamada K
    J Neurosurg; 2011 Jun; 114(6):1701-5. PubMed ID: 21375379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study.
    Williams DR; Lees AJ
    Lancet Neurol; 2005 Oct; 4(10):605-10. PubMed ID: 16168928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with drug-induced visual hallucinations in Parkinson's disease.
    Papapetropoulos S; Argyriou AA; Ellul J
    J Neurol; 2005 Oct; 252(10):1223-8. PubMed ID: 15834642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychotic symptoms in Parkinson's disease].
    Fénelon G
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4 Spec No 1():S17-24. PubMed ID: 23631044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between age and subtypes of psychotic symptoms in Parkinson's disease.
    Kiziltan G; Ozekmekçi S; Ertan S; Ertan T; Erginöz E
    J Neurol; 2007 Apr; 254(4):448-52. PubMed ID: 17401525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease.
    Merims D; Shabtai H; Korczyn AD; Peretz C; Weizman N; Giladi N
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1447-53. PubMed ID: 15480845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features associated with the development of hallucinations in Parkinson's disease.
    Benbir G; Ozekmekçi S; Cinar M; Beskardes F; Apaydin H; Erginöz E
    Acta Neurol Scand; 2006 Oct; 114(4):239-43. PubMed ID: 16942542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
    Kulick CV; Montgomery KM; Nirenberg MJ
    Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar affective disorder and Parkinson's disease: a rare, insidious and often unrecognized association.
    Cannas A; Spissu A; Floris GL; Congia S; Saddi MV; Melis M; Mascia MM; Pinna F; Tuveri A; Solla P; Milia A; Giagheddu M; Tacconi P
    Neurol Sci; 2002 Sep; 23 Suppl 2():S67-8. PubMed ID: 12548347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deconstructing psychosis and misperception symptoms in Parkinson's disease.
    Nishio Y; Yokoi K; Uchiyama M; Mamiya Y; Watanabe H; Gang M; Baba T; Takeda A; Hirayama K; Mori E
    J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):722-729. PubMed ID: 28600444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosis in Parkinson's disease.
    Poewe W
    Mov Disord; 2003 Sep; 18 Suppl 6():S80-7. PubMed ID: 14502660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.